Literature DB >> 17278131

Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes.

Michel Paré1, Phillip J Albrecht, Christopher J Noto, Noni L Bodkin, Gary L Pittenger, David J Schreyer, Xenia T Tigno, Barbara C Hansen, Frank L Rice.   

Abstract

Diabetic neuropathy (DN) is a common severe complication of type 2 diabetes. The symptoms of chronic pain, tingling, and numbness are generally attributed to small fiber dysfunction. However, little is known about the pathology among innervation to distal extremities, where symptoms start earliest and are most severe, and where the innervation density is the highest and includes a wide variety of large fiber sensory endings. Our study assessed the immunochemistry, morphology, and density of the nonvascular innervation in glabrous skin from the hands of aged nondiabetic rhesus monkeys and from age-matched monkeys that had different durations of spontaneously occurring type 2 diabetes. Age-related reductions occurred among all types of innervation, with epidermal C-fiber endings preferentially diminishing earlier than presumptive Adelta-fiber endings. In diabetic monkeys epidermal innervation density diminished faster, became more unevenly distributed, and lost immunodetectable expression of calcitonin gene-related peptide and capsaicin receptors, TrpV1. Pacinian corpuscles also deteriorated. However, during the first few years of hyperglycemia, a surprising hypertrophy occurred among terminal arbors of remaining epidermal endings. Hypertrophy also occurred among Meissner corpuscles and Merkel endings supplied by Abeta fibers. After longer-term hyperglycemia, Meissner corpuscle hypertrophy declined but the number of corpuscles remained higher than in age-matched nondiabetics. However, the diabetic Meissner corpuscles had an abnormal structure and immunochemistry. In contrast, the expanded Merkel innervation was reduced to age-matched nondiabetic levels. These results indicate that transient phases of substantial innervation remodeling occur during the progression of diabetes, with differential increases and decreases occurring among the varieties of innervation. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17278131     DOI: 10.1002/cne.21262

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  37 in total

Review 1.  Role of small-fiber afferents in pain mechanisms with implications on diagnosis and treatment.

Authors:  Phillip J Albrecht; Frank L Rice
Journal:  Curr Pain Headache Rep       Date:  2010-06

2.  Ageing of the somatosensory system at the periphery: age-related changes in cutaneous mechanoreceptors.

Authors:  Jorge García-Piqueras; Yolanda García-Mesa; Lucia Cárcaba; Jorge Feito; Isidro Torres-Parejo; Benjamín Martín-Biedma; Juan Cobo; Olivia García-Suárez; Jose A Vega
Journal:  J Anat       Date:  2019-03-29       Impact factor: 2.610

3.  Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus.

Authors:  Andrew D Patterson; Jessica A Bonzo; Fei Li; Kristopher W Krausz; Gabriel S Eichler; Sadaf Aslam; Xenia Tigno; John N Weinstein; Barbara C Hansen; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

4.  Keratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanisms.

Authors:  Quanzhi Hou; Travis Barr; Lucy Gee; Jeff Vickers; James Wymer; Elisa Borsani; Luigi Rodella; Spiro Getsios; Trisha Burdo; Elan Eisenberg; Udayan Guha; Robert Lavker; John Kessler; Sridar Chittur; Dennis Fiorino; Frank Rice; Phillip Albrecht
Journal:  Pain       Date:  2011-06-17       Impact factor: 6.961

Review 5.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

6.  Altered expression of glial markers, chemokines, and opioid receptors in the spinal cord of type 2 diabetic monkeys.

Authors:  Norikazu Kiguchi; Huiping Ding; Christopher M Peters; Nancy D Kock; Shiroh Kishioka; J Mark Cline; Janice D Wagner; Mei-Chuan Ko
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-14       Impact factor: 5.187

Review 7.  Uses of skin biopsy for sensory and autonomic nerve assessment.

Authors:  M Iliza Myers; Amanda C Peltier
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

Review 8.  Epidermal nerve fiber quantification in the assessment of diabetic neuropathy.

Authors:  Kristina K Beiswenger; Nigel A Calcutt; Andrew P Mizisin
Journal:  Acta Histochem       Date:  2008-04-01       Impact factor: 2.479

9.  Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Hongmei Zhang; Yan Li; Marianna de Carvalho-Barbosa; Annemieke Kavelaars; Cobi J Heijnen; Phillip J Albrecht; Patrick M Dougherty
Journal:  J Pain       Date:  2016-03-12       Impact factor: 5.820

10.  Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy.

Authors:  Megan S Johnson; Janelle M Ryals; Douglas E Wright
Journal:  Pain       Date:  2008-08-30       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.